ontilyv
bial portela & companhia s.a. - opicapone - parkinsons sygdom - anti-parkinson-lægemidler - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
ondansetron "bluefish" 8 mg smeltetabletter
bluefish pharmaceuticals ab - ondansetron - smeltetabletter - 8 mg
ondansetron "bluefish" 4 mg smeltetabletter
bluefish pharmaceuticals ab - ondansetron - smeltetabletter - 4 mg
ondansetron "paranova" 4 mg smeltetabletter
paranova danmark a/s - ondansetron - smeltetabletter - 4 mg
ondansetron "epione medicine" 4 mg smeltetabletter
epione medicine aps - ondansetron - smeltetabletter - 4 mg
durogesic 100 mikrogram/time depotplastre
janssen-cilag a/s - fentanyl - depotplastre - 100 mikrogram/time
durogesic 25 mikrogram/time depotplastre
janssen-cilag a/s - fentanyl - depotplastre - 25 mikrogram/time
durogesic 50 mikrogram/time depotplastre
janssen-cilag a/s - fentanyl - depotplastre - 50 mikrogram/time
durogesic 75 mikrogram/time depotplastre
janssen-cilag a/s - fentanyl - depotplastre - 75 mikrogram/time
fentanyl "mylan" 75 mikrogram/time depotplastre
mylan ab - fentanyl - depotplastre - 75 mikrogram/time